MOHANTY ADITYA P.

CIK 00016298194 companiesALAMEDA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001629819

Recent Transactions

37 trades

Tax Payment
BIORA THERAPEUTICS, INC.
Common Stock
2024-08-15$0.67/sh−70,883→ 1,468,609 total
Award
BIORA THERAPEUTICS, INC.
Common Stock
2024-02-15+819,000→ 1,539,492 total
Tax Payment
BIORA THERAPEUTICS, INC.
Common Stock
2023-08-15$3.14/sh−117,881→ 161,042 total
Award
BIORA THERAPEUTICS, INC.
Common Stock
2023-08-15+559,450→ 720,492 total
Tax Payment
BIORA THERAPEUTICS, INC.
Common Stock
2023-05-15$3.35/sh−11,249→ 278,923 total
Tax Payment
BIORA THERAPEUTICS, INC.
Common Stock
2023-03-15$2.56/sh−22,252→ 290,172 total
Award
BIORA THERAPEUTICS, INC.
Common Stock
2023-03-15+155,550→ 267,545 total
Award
BIORA THERAPEUTICS, INC.
Common Stock
2023-03-15+44,879→ 312,424 total
Disposition to Issuer
BIORA THERAPEUTICS, INC.
Series X Preferred Stock
2023-01-03−178→ 0 total
Tax Payment
BIORA THERAPEUTICS, INC.
Common Stock
2022-11-15$0.27/sh−175,071→ 2,799,858 total
Award
BIORA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2022-05-15+2,495,425→ 2,495,425 total
Award
BIORA THERAPEUTICS, INC.
Common Stock
2022-05-15+1,562,500→ 2,974,929 total
Award
BIORA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2021-11-08+2,086,898→ 2,086,898 total
Award
BIORA THERAPEUTICS, INC.
Common Stock
2021-11-08+1,412,429→ 1,412,429 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to Purchase Common Stock
2019-07-17+45,000→ 45,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to Purchase Common Stock
2019-02-15+33,750→ 33,750 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2018-07-10−4,687→ 32,813 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-07-10$2.20/sh−1,621→ 101,384 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-07-10+4,687→ 103,005 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-04-10$2.49/sh−1,622→ 98,318 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2018-04-10−4,688→ 37,500 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-04-10+4,688→ 99,940 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Option to Purchase Common Shares
2018-03-15+200,000→ 200,000 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-10-10+4,688→ 94,384 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2017-10-10−4,688→ 46,875 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-10-10$2.81/sh−1,762→ 92,622 total
Purchase
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-08-21$2.50/sh+7,500→ 89,696 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-07-10$3.09/sh−1,762→ 82,196 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-07-10+4,687→ 83,958 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2017-07-10−4,687→ 51,563 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Option to Purchase Common Shares
2017-06-06+650,000→ 650,000 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-04-10$3.33/sh−7,046→ 79,271 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-04-10+18,750→ 86,317 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2017-04-10−18,750→ 56,250 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2016-04-11$2.96/sh+67,567→ 67,567 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2016-04-11+75,000→ 75,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Option to Purchase Common Shares
2016-04-07+375,000→ 375,000 total

Companies

Recent Filings

Address

1301 HARBOR BAY PARKWAY

ALAMEDA, CA, 94502

View on SEC.gov